Hemopoiesis (also spelled hematopoiesis) is the process by which the bone marrow produces all blood cells: red cells, white cells, and platelets. It begins with a small pool of hematopoietic stem cells that can both renew themselves and mature into every blood cell type, guided by signals from the surrounding marrow tissue. When this process fails or goes wrong, the result can be anemia, infections, bleeding, or blood cancers.
This article explains where and how hemopoiesis happens, how it is controlled, what goes wrong in disease, and how doctors test and treat those problems. It is written for patients and caregivers, with enough detail to be useful to students reviewing blood cell development.
Where Hemopoiesis Happens
Blood production moves location during life. In the early embryo it starts in the yolk sac, shifts to the liver and spleen during fetal development, and settles in the bone marrow before birth. In young children, almost all bones contain active red marrow.
In adults, active marrow is concentrated in the flat bones and the ends of long bones: the pelvis, sternum, ribs, vertebrae, skull, and the upper ends of the femur and humerus. The rest gradually becomes fatty yellow marrow. Our article on the composition and function of bone marrow describes this tissue in more detail.
How Hemopoiesis Works: From Stem Cell to Blood Cell
Hemopoiesis follows a branching hierarchy. At the top are hematopoietic stem and progenitor cells (HSPCs). As they divide, their daughters become progressively more committed to one lineage.
- Myeloid progenitors give rise to red cells, platelets (from large cells called megakaryocytes), and the granulocytes and monocytes that fight infection.
- Lymphoid progenitors give rise to B cells, T cells, and natural killer cells.
The output is enormous. An adult makes hundreds of billions of new blood cells every day, matching production to the lifespan of each cell type.
| Process | Cell produced | Main growth factor | Approximate lifespan in blood |
|---|---|---|---|
| Erythropoiesis | Red blood cells | Erythropoietin (made mainly by the kidneys) | About 120 days |
| Thrombopoiesis | Platelets | Thrombopoietin (made mainly by the liver) | About 7–10 days |
| Granulopoiesis | Neutrophils and other granulocytes | G-CSF and GM-CSF | Hours to a few days |
| Lymphopoiesis | B and T lymphocytes | Interleukins such as IL-7 | Days to many years (memory cells) |
The Marrow Niche and Its Signals
Stem cells live in specialized micro-environments called niches, formed by stromal cells, blood vessel lining cells, bone-forming cells, and a supporting matrix. The niche releases growth factors and cytokines, chemical messengers that tell stem cells when to rest, renew, or mature.
Inside the cells, signaling pathways such as Notch and Wnt help decide cell fate, and transcription factors act like master switches for each lineage. GATA-1 and TAL1, for example, are central to the development of red cells and megakaryocytes. Disruption of these controls underlies many hematological disorders.
Feedback Control
Hemopoiesis responds to the body’s needs. When oxygen delivery falls, as in anemia or at high altitude, the kidneys release more erythropoietin and red cell production rises. During infection, white cell production increases. This feedback explains why a rising reticulocyte count signals a healthy marrow response after bleeding.
What Goes Wrong: Disorders of Hemopoiesis
Problems can arise at any step, from the stem cell to the final mature cell. Common causes include:
- Nutritional deficiencies: iron, vitamin B12, and folate are essential raw materials, and shortages cause anemia.
- Marrow failure: in aplastic anemia, the stem cell pool is depleted, often by an immune attack, leading to low counts of all cell types.
- Acquired genetic changes: myelodysplastic syndromes produce abnormal, ineffective cells; leukemias produce immature cells that crowd out normal ones. Chronic myeloid leukemia, for example, is driven by the BCR-ABL1 fusion gene.
- External damage: chemotherapy, radiation, some medications, heavy alcohol use, and certain viral infections can suppress the marrow.
- Marrow infiltration: cancers spreading into the marrow, or scarring (myelofibrosis), can displace normal tissue.
Symptoms When Hemopoiesis Fails
Symptoms follow the cell lines affected. Low red cells cause tiredness, pallor, and breathlessness; low white cells (leukopenia) cause frequent or severe infections; and low platelets (thrombocytopenia) cause easy bruising, nosebleeds, and bleeding gums. A fall in all three is called pancytopenia and always needs investigation.
How Doctors Evaluate the Marrow
Investigation starts with the blood and moves to the marrow if needed.
- Complete blood count (CBC): shows which cell lines are low or high.
- Reticulocyte count: measures how actively the marrow is making red cells.
- Peripheral blood smear: checks cell shape and looks for immature or abnormal cells.
- Bone marrow aspiration and biopsy: the definitive test for marrow cellularity and structure, usually taken from the back of the hip bone.
- Cytogenetics and molecular testing: chromosome analysis and gene sequencing identify mutations that drive marrow disorders and guide treatment.
Treatment and Clinical Implications
Understanding hemopoiesis has shaped modern treatment of blood disorders.
- Replacing raw materials: iron, B12, and folate correct deficiency anemias.
- Growth factors: erythropoiesis-stimulating agents and G-CSF boost red cell and neutrophil production in selected patients.
- Targeted therapy: tyrosine kinase inhibitors block the BCR-ABL1 signal in chronic myeloid leukemia.
- Immune therapy: immunosuppressive treatment can restore marrow function in some cases of aplastic anemia.
- Hematopoietic stem cell transplantation: replaces a failing or diseased marrow with healthy stem cells and can be curative for some conditions.
- Supportive care: transfusions and antibiotics bridge patients through periods of low counts.
Research into single-cell analysis and gene editing is steadily refining our picture of how stem cells choose their fate, and gene-based therapies are beginning to reach patients with some inherited blood disorders.
Key Takeaways
- Hemopoiesis is the continuous production of blood cells from stem cells in the bone marrow.
- It is tightly controlled by the marrow niche, growth factors such as erythropoietin and thrombopoietin, and internal genetic switches.
- Failures cause anemia, infections, and bleeding, while uncontrolled growth leads to leukemias and related disorders.
- The CBC, smear, and bone marrow biopsy are the main tools for evaluating marrow health.
If you have persistent fatigue, repeated infections, or unexplained bruising, ask your doctor about a blood count. More information on hematological conditions is available in our patient guides.
Frequently Asked Questions
Is hemopoiesis the same as hematopoiesis?
Yes. Both terms describe the formation of blood cells; “hemopoiesis” is simply a shorter spelling. You may also see “haematopoiesis” in British texts.
Can the bone marrow recover after chemotherapy?
In most cases, yes. Chemotherapy temporarily suppresses dividing marrow cells, and counts usually recover over a few weeks as stem cells repopulate the marrow. Growth factors may be used to speed recovery of white cells.
Does blood production slow with age?
The amount of active red marrow decreases with age, and stem cells become less adaptable, but a healthy older adult still produces enough blood cells. New or unexplained low counts in older people should be investigated rather than put down to age.
Why does the kidney matter for red cell production?
The kidneys make most of the body’s erythropoietin, the hormone that drives red cell production. In chronic kidney disease, erythropoietin levels fall and anemia is common.
